Rapid COVID-19 Test Available Now
54 Samples | 54o Tests | 4 Hours
Randox has developed a rapid test for COVID-19 (SARS-CoV-2), the new strain of coronavirus.
The only test in the world that can identify the lethal strain and differentiate between other non-lethal variants with the same symptoms.
The new test utilises Randox Biochip Technology, reporting 540 results in less than 5 hours on the Randox Evidence Investigator, a semi-automated analyser that is capable of processing 54 patient samples simultaneously.
Extended Coronavirus Array
Five strains of coronavirus including SARS-CoV-2 (SARS-CoV-2, 229E, NL63, OC43 and HKUI) are detected on this panel. The wider panel provides a more comprehensive respiratory screen enabling informed treatment decisions to be made.
| VIRUSES | |
|---|---|
| SARS-CoV-2 (COVID-19) | Adenovirus A/B/C/D/E |
| Sarbecovirus (SARS, SARS like, SARS-CoV-2) | Enterovirus A/B/C |
| Coronavirus 229E/NL63 | Influenza A |
| Coronavirus OC43/HKUI | Influenza B |
| Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | Rhinovirus A/B |
Randox | Investigator
The Evidence Investigator is a compact semi-automated benchtop analyser. It is a perfect fit for medium throughput laboratories seeking maximum use of bench space without compromising on the volume of samples processed.
- Estimated turnaround time of less than 5 hours
- Medium to high throughput (Capable of processing 54 samples and reporting 540 results in less than 5 hours)
- Detection from nucleic acid
- Batch testing
- Suitable for laboratory setting
- Comprehensive test menu
